H1030 - 2016 Appropriations Act. (SL 2016-94)

Overview: Sec. 12F.1 of S.L. 2016-94 creates a three-year pilot program conducted by designated federally qualified health centers located in North Carolina and overseen by the Department of Health and Human Services to study the effectiveness of combining behavioral therapy with the utilization of a nonnarcotic, nonaddictive, extended-release injectable formulation of opioid antagonist approved by the United States Food and Drug Administration, for the prevention of relapse to opioid dependence.

This section became effective July 14, 2016.